Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

Stem Cell Related Donor Safety Study
A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
Status: Enrolling
Updated:  6/13/2017
mi
from
Saint Louis, MO
Stem Cell Related Donor Safety Study
A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
Status: Enrolling
Updated: 6/13/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Stem Cell Related Donor Safety Study
A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
Status: Enrolling
Updated:  6/13/2017
mi
from
Winston-Salem, NC
Stem Cell Related Donor Safety Study
A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
Status: Enrolling
Updated: 6/13/2017
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Cleveland, OH
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Durham, NC
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Boston, MA
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Milwaukee, WI
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Columbus, OH
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Chicago, IL
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Minneapolis, MN
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Morgantown, WV
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Tampa, FL
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Atlanta, GA
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Rochester, MN
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated:  6/13/2017
mi
from
Saint Louis, MO
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies
Status: Enrolling
Updated: 6/13/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
A Phase I Study of Vaccination With Autologous CD40-Activated Acute Lymphoblastic Leukemia Cells
Status: Enrolling
Updated:  6/19/2017
mi
from
Boston, MA
Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
A Phase I Study of Vaccination With Autologous CD40-Activated Acute Lymphoblastic Leukemia Cells
Status: Enrolling
Updated: 6/19/2017
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
A Phase I Study of Vaccination With Autologous CD40-Activated Acute Lymphoblastic Leukemia Cells
Status: Enrolling
Updated:  6/19/2017
mi
from
Boston, MA
Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
A Phase I Study of Vaccination With Autologous CD40-Activated Acute Lymphoblastic Leukemia Cells
Status: Enrolling
Updated: 6/19/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Improving Patient Education for Lymphoma and Leukemia Inpatients
Improving Patient Education for Newly Diagnosed Lymphoma and Acute Leukemia Inpatients
Status: Enrolling
Updated:  6/21/2017
mi
from
Atlanta, GA
Improving Patient Education for Lymphoma and Leukemia Inpatients
Improving Patient Education for Newly Diagnosed Lymphoma and Acute Leukemia Inpatients
Status: Enrolling
Updated: 6/21/2017
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
Phase 1 Study to Assess Tolerability, PK and PD Activity of ON 01910.Na Administered Orally as Escalating Single and Multiple Doses Twice a Day up to 14 Days of a 21-Day Cycle in Patients With Myelodysplastic Syndrome
Status: Enrolling
Updated:  6/22/2017
mi
from
Tampa, FL
Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
Phase 1 Study to Assess Tolerability, PK and PD Activity of ON 01910.Na Administered Orally as Escalating Single and Multiple Doses Twice a Day up to 14 Days of a 21-Day Cycle in Patients With Myelodysplastic Syndrome
Status: Enrolling
Updated: 6/22/2017
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
Phase 1 Study to Assess Tolerability, PK and PD Activity of ON 01910.Na Administered Orally as Escalating Single and Multiple Doses Twice a Day up to 14 Days of a 21-Day Cycle in Patients With Myelodysplastic Syndrome
Status: Enrolling
Updated:  6/22/2017
mi
from
New York, NY
Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
Phase 1 Study to Assess Tolerability, PK and PD Activity of ON 01910.Na Administered Orally as Escalating Single and Multiple Doses Twice a Day up to 14 Days of a 21-Day Cycle in Patients With Myelodysplastic Syndrome
Status: Enrolling
Updated: 6/22/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
A Phase 1/2, Single-Arm Study To Assess The Efficacy and Safety Of 5-day Continuous Intravenous Dosing Of ON 01910.Na Administered Every 2 Weeks in Patients With Intermediate-1, Intermediate-2, or High Risk Myelodysplastic Syndrome (MDS)
Status: Enrolling
Updated:  6/22/2017
mi
from
New York, NY
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
A Phase 1/2, Single-Arm Study To Assess The Efficacy and Safety Of 5-day Continuous Intravenous Dosing Of ON 01910.Na Administered Every 2 Weeks in Patients With Intermediate-1, Intermediate-2, or High Risk Myelodysplastic Syndrome (MDS)
Status: Enrolling
Updated: 6/22/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Castro Valley, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Valley Medical Oncology Consultants - Castro Valley
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Castro Valley, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
East Bay Radiation Oncology Center
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Fremont, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Valley Medical Oncology
mi
from
Fremont, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Martinez, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Contra Costa Regional Medical Center
mi
from
Martinez, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Mountain View, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
El Camino Hospital Cancer Center
mi
from
Mountain View, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Oakland, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Bay Area Breast Surgeons, Incorporated
mi
from
Oakland, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Oakland, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Oakland, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Tom K Lee, Incorporated
mi
from
Oakland, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Oakland, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Alta Bates Summit Medical Center - Summit Campus
mi
from
Oakland, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Lewes, DE
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Tunnell Cancer Center at Beebe Medical Center
mi
from
Lewes, DE
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Chicago, IL
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Louis A. Weiss Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
La Grange, IL
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
La Grange Memorial Hospital
mi
from
La Grange, IL
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Rockford, IL
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Center for Cancer Care at OSF Saint Anthony Medical Center
mi
from
Rockford, IL
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Elkhart, IN
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Michiana Hematology-Oncology
mi
from
Elkhart, IN
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Elkhart, IN
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Elkhart, IN
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Elkhart General Hospital
mi
from
Elkhart, IN
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
La Porte, IN
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Mishawaka, IN
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Saint Joseph Regional Medical Center
mi
from
Mishawaka, IN
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Plymouth, IN
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Michiana Hematology Oncology
mi
from
Plymouth, IN
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
South Bend, IN
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Iowa City, IA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Overland Park, KA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Menorah Medical Center
mi
from
Overland Park, KA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Boston, MA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Dana-Farber/Brigham and Women's Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Boston, MA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Niles, MI
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Michiana Hematology Oncology PC - Niles
mi
from
Niles, MI
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Saint Joseph, MI
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Lakeside Cancer Specialists, PLLC
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Kansas City, MO
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Parvin Radiation Oncology
mi
from
Kansas City, MO
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Kansas City, MO
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Kansas City, MO
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
St. Joseph Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
mi
from
Kansas City, MO
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
North Kansas City Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials